|
End-of-day quote
Taiwan S.E.
22/10/2026
|
5-day change | 1st Jan Change | ||
| 49.70 TWD | +0.71% |
|
-0.30% | -19.45% |
| 10-07 | EirGenix Submits European Marketing Application for Breast Cancer Biosimilar | MT |
| 09-10 | EirGenix Completes Capital Reduction Following RSA Write-Off | MT |
| Market Cap | 14.84B 455M 406M 375M 341M 639M 43.11B 649M 4.51B 1.78B 22.59B 1.71B 1.67B 71.55B | P/E 2026 * |
-32.7x | P/E 2027 * | 87.2x |
|---|---|---|---|---|---|
| Enterprise Value | 13.6B 417M 372M 343M 312M 585M 39.49B 594M 4.14B 1.63B 20.69B 1.56B 1.53B 65.54B | EV / Sales 2026 * |
9.22x | EV / Sales 2027 * | 5.98x |
| Free-Float |
59.34% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.71% | ||
| 1 week | -0.30% | ||
| Current month | -6.93% | ||
| 1 month | -4.24% | ||
| 3 months | +6.65% | ||
| 6 months | +1.74% | ||
| Current year | -19.45% |
| 1 week | 48.6 |  | 50.8 |
| 1 month | 48.6 | | 54 |
| Current year | 40.15 | | 67.6 |
| 1 year | 40.15 | | 84.3 |
| 3 years | 40.15 | | 111 |
| 5 years | 40.15 | | 163.5 |
| 10 years | 21.55 | | 195 |
| Manager | Title | Age | Since |
|---|---|---|---|
Li Cheng Liu
CEO | Chief Executive Officer | - | 01/04/2013 |
Hsiu Chuan Yang
DFI | Director of Finance/CFO | - | 03/05/2016 |
Yu Wen Liu
PRN | Corporate Officer/Principal | - | 20/05/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Cheng Yue Cheng
BRD | Director/Board Member | - | 14/06/2013 |
Hsiu Hui Chen
BRD | Director/Board Member | - | 13/09/2016 |
Li Cheng Liu
CHM | Chairman | - | 10/06/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.71% | -0.30% | -29.20% | -48.23% | 455M | |
| +2.83% | +4.40% | +60.84% | +123.50% | 1,165B | |
| +3.81% | +5.66% | +38.70% | +74.91% | 645B | |
| +0.14% | +0.63% | +24.71% | +95.03% | 504B | |
| -0.20% | +2.85% | +43.59% | +64.18% | 380B | |
| -1.76% | +1.41% | +68.06% | +43.41% | 363B | |
| -0.23% | +2.89% | +22.75% | +51.83% | 297B | |
| -1.50% | +2.54% | +2.13% | +26.36% | 269B | |
| +2.04% | +3.05% | +51.12% | +60.42% | 237B | |
| +2.36% | -0.11% | +29.42% | +102.04% | 195B | |
| Average | -0.10% | +2.02% | +31.21% | +59.35% | 405.59B | |
| Weighted average by Cap. | -0.16% | +3.17% | +43.08% | +83.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.47B 45.2M 40.34M 37.22M 33.81M 63.43M 4.28B 64.41M 448M 177M 2.24B 170M 166M 7.11B | 2.34B 71.84M 64.13M 59.16M 53.75M 101M 6.81B 102M 713M 281M 3.57B 270M 264M 11.29B |
| Net income | -458M -14.04M -12.54M -11.56M -10.51M -19.71M -1.33B -20.01M -139M -54.88M -697M -52.71M -51.58M -2.21B | 172M 5.27M 4.71M 4.34M 3.95M 7.4M 500M 7.52M 52.32M 20.61M 262M 19.8M 19.37M 829M |
| Net Debt | -1.25B -38.24M -34.13M -31.49M -28.61M -53.67M -3.62B -54.49M -379M -149M -1.9B -144M -140M -6.01B | -838M -25.7M -22.94M -21.16M -19.22M -36.06M -2.43B -36.62M -255M -100M -1.28B -96.45M -94.38M -4.04B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/10/26 | NT$49.70 | +0.71% | 290,030 |
| 21/10/26 | NT$49.35 | +0.51% | 232,203 |
| 20/10/26 | NT$49.10 | +0.61% | 238,581 |
| 19/10/26 | NT$48.80 | -4.50% | 494,391 |
| 16/10/26 | NT$51.10 | +2.51% | 484,460 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6589 Stock
Select your edition
All financial news and data tailored to specific country editions
